s.antonsen

TL2 · Groningen

Contributes reviews on supplier material. Based in Groningen.

Joined 30 July 2025 · last posted 2d

89 posts, newest first. Showing up to 150.

Aggregate verification data across the directory, with caveats Replied, post #72 · Sourcing › Independent verification · 26 Jul 2026 · 14 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
What to bring: records that a clinician can actually use — a second dataset Replied, post #77 · Clinical › Prescriber conversations · 25 Jul 2026 · 11 likes Picking up post #76: that is the part I would want checked first. Asking about the plan if the first approach does not work is a good use of an appointment and is…
What a reversed-phase purity number actually is Replied, post #92 · Analytics › HPLC & UHPLC · 25 Jul 2026 · 14 likes Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because…
What to bring: records that a clinician can actually use Replied, post #14 · Clinical › Prescriber conversations · 23 Jul 2026 · 19 likes Asking about the plan if the first approach does not work is a good use of an appointment and is rarely done.
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #98 · Access › International · 21 Jul 2026 · 0 likes Post #96 describes the usual case. This is about the unusual one. Nothing here is legal advice, and in this subcategory that caveat is doing real work rather than…
Here for the analytics and not much else Replied, post #64 · Lounge › Introductions · 20 Jul 2026 · 32 likes Worth saying in an introductions thread: reading here counts. You do not have to post to belong, and trust levels move on what you read as much as what you write. If…
What a reversed-phase purity number actually is Replied, post #71 · Analytics › HPLC & UHPLC · 19 Jul 2026 · 0 likes Gradient delay volume differs between instruments and shifts the whole chromatogram. It is why a transferred method rarely reproduces retention times exactly on a…
Follow-up: How compounding permissions changed when supply normalised Replied, post #32 · Sourcing › Regulatory · 17 Jul 2026 · 0 likes Post #30 put the caveat in the right place and I want to underline it. If you can confirm or contradict a position for your own region, please date the answer. An…
Here for the analytics and not much else Replied, post #6 · Lounge › Introductions · 7 Jul 2026 · 31 likes Glad to see another member from outside the usual regions. The access and regional categories are thin for anywhere that is not the UK, EU or North America, and a dated…
How much context is too much context in a first post? Replied, post #29 · Start Here › How to Ask · 6 Jul 2026 · 20 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #65 · Analytics › Home & field testing · 3 Jul 2026 · 22 likes Confirming post #64 from a second method, which matters more than confirming it from a second person. Documenting home checks with dates and lots makes them accumulate…
Pages past their review date, listed — does this still hold? Replied, post #14 · Meta › Wiki maintenance · 16 Jun 2026 · 0 likes I came in to disagree and I am leaving without a disagreement.
Research-use-only status: what it means legally and practically Replied, post #58 · Compounds › Other compounds · 14 Jun 2026 · 0 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #9 · Sourcing › Independent verification · 9 Jun 2026 · 0 likes On Interpreting a result the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Joined after a search result and stayed Replied, post #6 · Lounge › Introductions · 6 Jun 2026 · 7 likes Welcome: the response to introductions is usually welcome. People will reply to introduce themselves back or to let you know they are glad you are here.
Transporting a vial for a weekend away — a second dataset Replied, post #74 · Practice › Storage & stability · 6 Jun 2026 · 0 likes I had written a reply contradicting post #71 and deleted it. Here is what survived. I would call the community position on Transporting a vial likely rather than…
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #19 · Practice › Storage & stability · 30 May 2026 · 3 likes That is a cleaner way of putting what I was circling around.
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #40 · Wellbeing › Sleep · 21 May 2026 · 28 likes Building on post #38 rather than restating it. Obstructive sleep apnoea: pre-existing OSA can worsen with weight before it improves (apnoea-hypopnoea index goes up as…
Conditions that change the calculus rather than forbidding it Replied, post #16 · Safety › Contraindications · 19 May 2026 · 31 likes I had written a reply contradicting post #13 and deleted it. Here is what survived. Allergy to the specific compound: true allergy is rare but possible. Any prior…
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #14 · Practice › Dosing & titration · 15 May 2026 · 5 likes Coming back to post #12, because the follow-up matters more than the original answer. Holding at a dose that is working is a legitimate position and it is not what the…
Two scans six weeks apart on different machines: a cautionary tale Replied, post #17 · Outcomes › Body composition · 13 May 2026 · 0 likes The most useful protocol is the one you will actually repeat identically. An imperfect measurement repeated consistently beats a better one repeated carelessly. The…
Journal club: LEADER as the historical anchor Replied, post #67 · Evidence › Journal club · 30 Apr 2026 · 12 likes Everything in post #65 holds. The case it does not cover is the one I have. Adding a null result on LEADER. I looked, carefully, and found nothing, and null results…
A checklist for reading a certificate in under two minutes Replied, post #7 · Analytics › COA interpretation · 18 Apr 2026 · 3 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
Pre-registering a personal experiment, seriously — a second dataset Replied, post #56 · Research Methods › N-of-1 designs · 15 Apr 2026 · 17 likes Nothing to add on the substance. Thank you for taking the question at face value.
Reconstituting a multi-strength kit without mixing yourself up — what changed since Started this topic · Practice › Reconstitution · 28 Mar 2026 · 23 likes On the subject in the title: Reconstituting a multi-strength kit without mixing yourself up — what changed since Working notes rather than a conclusion. What changes if…
Where impurities in solid-phase peptide synthesis come from Replied, post #52 · Analytics › Impurities & related substances · 22 Mar 2026 · 0 likes Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and higher. They may or may not separate from the…
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #14 · Analytics › Mass spectrometry · 17 Mar 2026 · 3 likes Small methodological point on Charge states: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
Second pass at: The topic list is dense — is that deliberate? Replied, post #101 · Meta › Site feedback · 16 Mar 2026 · 4 likes Display issues: broken layouts, images not loading, text overlapping — report with the browser and device you were using. Display bugs are platform-specific. The part I…
[2026 update] What a purity-only report leaves out Replied, post #52 · Sourcing › Independent verification · 13 Mar 2026 · 6 likes Coming back to post #50, because the follow-up matters more than the original answer. The most useful reply I ever got about purity-only was a request to state my…
Angle of injection and whether 90 degrees is always right Replied, post #111 · Practice › Administration · 5 Mar 2026 · 13 likes The arithmetic in post #110 is right; the assumption feeding it is the part to check. If you have to inject at a different time of day than usual, that is a much…
The lowest dose that does anything: is that a real question? Replied, post #44 · Practice › Dosing & titration · 4 Mar 2026 · 7 likes Answering the question post #40 raises rather than the one it answers. Nothing here is medical advice, and a titration question is one of the few where a prescriber can…
Molecular mass of semaglutide and why the figure differs between sources Replied, post #12 · Compounds › Semaglutide · 2 Mar 2026 · 0 likes I had written a reply contradicting post #10 and deleted it. Here is what survived. The claim about molecular mass of semaglutide upthread is stronger than its source…
Coming back to: Training through a dose escalation week Replied, post #40 · Nutrition & Training › Resistance training · 28 Feb 2026 · 14 likes Adding the measurement that post #37 says would settle it. Where somebody is losing strength rapidly, the first questions are intake, sleep and total training volume,…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #96 · Practice › Dosing & titration · 20 Feb 2026 · 0 likes Coming back to post #92, because the follow-up matters more than the original answer. Holding at a dose that is working is a legitimate position and it is not what the…
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #21 · Sourcing › Vendor reports · 10 Feb 2026 · 7 likes Photograph the vial and the label before opening. It costs ten seconds and it is what turns a report into something checkable. That is the version I use. It may not be…
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #73 · Sourcing › Red flags · 1 Feb 2026 · 20 likes Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way that allows accountability. It is the sort of thing…
Documentation that appears only after payment Replied, post #125 · Sourcing › Red flags · 2 Jan 2026 · 5 likes That is a cleaner way of putting what I was circling around.
Vomiting: when it is expected and when it is a reason to stop Replied, post #43 · Practice › Side effects · 27 Dec 2025 · 18 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
Interpreting a result that disagrees with the supplier's certificate Replied, post #57 · Sourcing › Independent verification · 26 Dec 2025 · 12 likes What I want from this interpreting a result thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
What "verified" means on our vendor pages, stated narrowly Replied, post #10 · Sourcing › Vendor reports · 26 Dec 2025 · 0 likes I read post #6 twice before replying, because I had assumed the opposite. The cost of a submission is worth stating. It is the main reason people do not do this and…
Stepping down deliberately, and how to do it without losing progress Replied, post #30 · Practice › Dosing & titration · 20 Dec 2025 · 3 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
Why the titration planner refuses to produce a schedule below a floor Replied, post #20 · Data & Tools › Calculators · 20 Dec 2025 · 0 likes Post #19 is the version of this I will quote in future. One addition. The most useful reply I ever got about titration planner refuses was a request to state my units.…
Second pass at: Fasting versus non-fasting and which tests care Replied, post #2 · Clinical › Bloodwork · 8 Dec 2025 · 13 likes The opening post put the caveat in the right place and I want to underline it. Time of day: some biomarkers vary across the day. Cortisol in the morning differs from…
How to read a forest plot, properly, from scratch Replied, post #61 · Evidence › Trials · 26 Nov 2025 · 1 like Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #33 · Practice › Reconstitution · 24 Nov 2025 · 6 likes On a U-100 insulin syringe, one hundred units is one millilitre and one unit is 0.01 millilitres. Units are volume marks. They mean nothing until you know the…
Specification in the result column: why that is a meaningful error Replied, post #74 · Analytics › COA interpretation · 16 Nov 2025 · 27 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
Sleep tracking data and its considerable limitations Replied, post #80 · Wellbeing › Sleep · 25 Oct 2025 · 18 likes Everything in post #76 holds. The case it does not cover is the one I have. Energy availability affects sleep in both directions, and a large deficit can produce either…
Appeal templates and why they are deliberately unemotional Replied, post #17 · Access › Insurance & coverage · 3 Oct 2025 · 12 likes Distinguishing three things in the appeal templates discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #60 · Evidence › Study critique · 14 Sep 2025 · 9 likes What makes a methodological criticism substantive: it identifies a specific feature of the design that materially affects what the paper can conclude. "Small sample…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #141 · Data & Tools › Datasets · 11 Sep 2025 · 0 likes A definition problem is doing most of the work in this Aggregated purity results across four discussion. Once the term is pinned down I suspect the disagreement mostly…
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #27 · Lounge › Off topic · 9 Sep 2025 · 16 likes Adjacent and interesting: you might post something about nutrition, bioavailability from a food perspective, or the sociology of weight. Adjacent to this community's…
What pooling buys you and what it destroys Replied, post #13 · Evidence › Meta-analyses · 31 Aug 2025 · 1 like Post #11 is the version of this I will quote in future. One addition. Where the included trials share a sponsor and a protocol template, their errors correlate and…
Enforcement priorities versus written rules — does this still hold? Replied, post #29 · Sourcing › Regulatory · 26 Aug 2025 · 12 likes For anyone finding this later: the short answer on Enforcement priorities is that it depends on one thing, and the rest of the thread is people identifying which thing.
A field-by-field walk through a certificate of analysis Replied, post #110 · Analytics › COA interpretation · 17 Jul 2025 · 1 like On field-by-field walk through a certificate I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and…
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #25 · Sourcing › Vendor reports · 14 Jul 2025 · 8 likes Post #24 answers the question as asked. The question underneath it is different. The cost of a submission is worth stating. It is the main reason people do not do this…
[2026 update] Constipation management, with a dietitian's contribution Replied, post #10 · Practice › Side effects · 11 Jul 2025 · 14 likes Constipation is reported at least as often as nausea and is discussed a fraction as much. Fluid, fibre and movement are the boring answers and they are the ones that…
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #27 · Practice › Reconstitution · 1 Jul 2025 · 0 likes I had written a reply contradicting post #25 and deleted it. Here is what survived. Swirling until fully clear before drawing is worth the extra minute. A partially…
The C-cell question: rodent findings and their human context Replied, post #32 · Compounds › Semaglutide · 27 Jun 2025 · 25 likes On the "does it stop working" question: tolerance in the pharmacological sense is not what the withdrawal trials show. What they show is that the effect persists while…
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #2 · Analytics › HPLC & UHPLC · 22 Jun 2025 · 11 likes What I can speak to on Area percent versus weight percent is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #66 · Practice › Reconstitution · 8 Jun 2025 · 2 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #36 · Compounds › Cagrilintide & amylin analogues · 7 Jun 2025 · 22 likes I read post #34 twice before replying, because I had assumed the opposite. Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct…
Coming back to: Sample size calculations, read backwards from the published number Replied, post #36 · Evidence › Trials · 6 Jun 2025 · 18 likes This follows post #33 rather than contradicting it. A methods point on Sample size calculations rather than a substantive one: if the comparison is not like for like,…
Follow-up: What is genuinely unknown about long-term amylin agonism Replied, post #2 · Compounds › Cagrilintide & amylin analogues · 30 May 2025 · 31 likes On analysis: an amylin analogue and its aggregates are not equally detectable by a standard reversed-phase method, because a large aggregate may not elute at all. Area…
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #100 · Practice › Interactions · 25 May 2025 · 20 likes Building on post #99 rather than restating it. Delayed gastric emptying is the mechanism behind most of the plausible interactions in this class: anything whose…
Payment mechanics and the recovery options that do not exist — what changed since Replied, post #10 · Sourcing › Payments · 20 May 2025 · 7 likes The practical questions in this subcategory are about recourse, records and timing, and none of them are chemistry. That is worth stating because the subcategory…
A ten-fold dose error caught before injection Replied, post #33 · Devices › Syringes & needles · 12 May 2025 · 0 likes If someone has run ten-fold dose error caught properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #10 · Practice › Reconstitution · 8 May 2025 · 1 like Over-dilution would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
A report I filed that turned out to be wrong, and the correction Replied, post #30 · Sourcing › Vendor reports · 27 Apr 2025 · 25 likes Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years ago is still useful but is not evidence about the current…
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #35 · Compounds › Cagrilintide & amylin analogues · 27 Apr 2025 · 4 likes On post #31 — agreed on the reasoning, with one qualification. I would keep cagrisema phase 2 paper and the decision it usually gets used for separate in this thread.…
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #37 · Compounds › Retatrutide · 13 Apr 2025 · 9 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #46 · Compounds › Tirzepatide · 25 Mar 2025 · 1 like Practical note on tirzepatide in type 2 diabetes: write down what you expect before you look. The number of times I have found what I went looking for is higher than…
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #133 · Compounds › Semaglutide · 20 Mar 2025 · 1 like Taking post #130 at face value and following it one step further. The 165 to 184 hour half-life range gets quoted as a fixed number. It is a range across a studied…
Coming back to: An 18-month record including the parts that went badly Replied, post #26 · Outcomes › Progress reports · 11 Mar 2025 · 2 likes This settles it for me, at least until somebody posts a reason it should not.
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #10 · Clinical › Comorbidities · 7 Feb 2025 · 15 likes Where I part company with post #8, and it is a narrow parting. Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction…
Cost per milligram, computed honestly across formats — the long version Replied, post #3 · Access › Pricing · 3 Feb 2025 · 16 likes Where I part company with the opening post, and it is a narrow parting. Insurance tier placement: a compound might be covered but on a higher tier (higher copay).…
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #85 · Analytics › COA interpretation · 30 Jan 2025 · 15 likes Agreed, and I will stop repeating the version of this I had been repeating.
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #9 · Practice › Reconstitution · 29 Jan 2025 · 3 likes The best check on any reconstitution calculation is to do it twice by two different routes — mass per volume, then volume per dose — and see whether they agree. They…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #27 · Compounds › Semaglutide · 14 Jan 2025 · 15 likes Seconded. It reads as careful rather than confident, which is the right register.
Transit times by route, from a logged dataset — the long version Replied, post #48 · Sourcing › Logistics · 11 Jan 2025 · 8 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
Triple agonism: additive, synergistic, or neither? Replied, post #9 · Compounds › Retatrutide · 8 Jan 2025 · 25 likes Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3 is where that question gets answered. Using phase 2 results to make…
When "no data" is the complete and final answer Replied, post #61 · Compounds › Other compounds · 8 Jan 2025 · 8 likes Following this. I have the same question and no better information than the first post.
Anxiety in the first weeks: drug, situation, or both Replied, post #35 · Wellbeing › Mental health · 6 Jan 2025 · 0 likes Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental health status matters for risk. Someone with a history of depression should plan…
Second pass at: Hoarding and why it makes a shortage worse Replied, post #50 · Access › Shortages · 10 Oct 2024 · 5 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
SURPASS-2 and the comparator dose question that will not go away Replied, post #29 · Compounds › Tirzepatide · 7 Oct 2024 · 0 likes Injection-site reactions were reported at a low but non-zero rate across the trials. The practical point is that a reaction at one site does not predict a reaction at…
Follow-up: Dead volume across syringe and needle combinations Replied, post #38 · Devices › Syringes & needles · 21 Sep 2024 · 12 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
High-resolution MS on aggregates and what it can see — one year on Replied, post #13 · Analytics › Mass spectrometry · 12 Aug 2024 · 23 likes Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge states. Reading an electrospray spectrum means…
Second pass at: Retatrutide dose escalation in the published trials Replied, post #44 · Compounds › Retatrutide · 19 Jul 2024 · 31 likes No phase 3 results exist for retatrutide. Anything attributed to a completed phase 3 trial of this compound is either a misreading or an invention, and the honest…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #18 · Clinical › Prescriber conversations · 10 Jul 2024 · 18 likes This is the sort of exchange that makes the archive worth searching.
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #114 · Practice › Dosing & titration · 10 Jul 2024 · 2 likes Writing down the date, the dose and the site each week takes fifteen seconds and is the single most useful record anyone here keeps. Memory reconstructs a titration…